ยินดีต้อนรับกลับมา
เข้าร่วม CoinTime
เข้าสู่ระบบ email
สร้างบัญชี email
ตรวจสอบกล่องจดหมายของคุณ
Livongo
About
Livongo provides a data science and technology enabled platform for detection of diabetes.
- Mountain View,California,United States
- 251 - 500
- https://hello.livongo.com
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $44.50M
- Industries
- Health Care,Health Diagnostics,Information Technology,Medical,Wellness
- Founded date
- Jan 1, 2008
- Number Of Employee
- 251 - 500
- Operating Status
- Active
- Stock Symbol
- nasdaq:LVGO
- Legal Name
- Livongo Health, Inc.
Livongo is the consumer digital health company that empowers people with chronic conditions to live a better life. It has developed a completely new approach for diabetes management that combines the latest technology with coaching. By offering the right information, tools, and support, at the right time, we provide our members with real-time, personalized insights, and support to make diabetes management easier. Its approach is leading to better financial and clinical outcomes while also creating a better experience for people with diabetes and their care team of family, friends, and medical professionals. It was founded in 2008 and is headquartered in Mountain View, California.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 25, 2019 | IPO | $355M | — | — | — | Detail |
| Apr 11, 2018 | Series E | $104.99M | 10 |
General Catalyst
Kinnevik
|
— | Detail |
| Mar 16, 2017 | Series D | $52.50M | 14 |
General Catalyst
Kinnevik
|
— | Detail |
| Apr 12, 2016 | Series C | $44.50M | 11 | — | — | Detail |
| Apr 7, 2015 | Series B | $20M | 2 |
Kleiner Perkins
|
— | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
General Catalyst
|
Yes | Series E |
|
Kinnevik
|
Yes | Series E |
7wire Ventures
|
— | Series E |
|
|
— | Series E |
|
Kleiner Perkins
|
— | Series E |
M12 - Microsoft's Venture Fund
|
— | Series E |
Merck Global Health Innovation Fund
|
— | Series E |
Sapphire Ventures
|
— | Series E |
|
|
— | Series E |
Zaffre Investments
|
— | Series E |
Employee Profiles
Acquisition
Livongo has acquired 3 organizations. Their most recent acquisition was Diabeto on Sep 13, 2017. They acquired Diabeto for 0.
